Abstract
Increasing cellular cholesterol levels results in high amyloid beta (Aβ) synthesis, which is central to the pathogenesis of Alzheimer's disease (AD). Heme oxygenase-1 (HO-1) stimulates oxidation of glial cholesterol to oxysterols, and increased oxysterol concentrations may protect neural tissues by activation of liver X receptor-β (LXR-β), which induces transcription of genes associated with reduction of cellular cholesterol concentrations and decrease of Aβ formation. Underexpression of HO-1 in concert with underexpression of LXR-β would result in increased cholesterol accumulation, induction of Aβ production, and increased AD risk. We examined a functional polymorphism in the HO-1 promoter region (−413, rs2071746), and three LXR-β polymorphisms in introns 2 (rs2695121), 5 (rs1052533), and 7 (rs1405655), in a group of 414 Spanish AD cases and 442 controls. Subjects carrying both the HO-1 (−413) TT genotype and the LXR-β (intron 2) TT genotype (OR=2.63), LXR-β (intron 5) AA genotype (OR=1.90), or LXR-β (intron 7) TT genotype (OR=1.75) had a higher risk of developing AD than subjects without these risk genotypes. Considering synergistic effects between polymorphisms in cellular cholesterol efflux-related genes may help in determining the risk profile for AD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
